XS
BIIB icon

XR Securities’s Biogen BIIB Stock Holding History

XR Securities’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,500
Closed -$539K – 252
2024
Q1 		$539K Sell
2,500
-1,300
-34% -$304K 0.02% 195
2023
Q4 		$983K Buy
3,800
+200
+6% +$49.1K 0.04% 192
2023
Q3 		$925K Sell
3,600
-1,300
-27% -$348K 0.07% 174
2023
Q2 		$1.4M Buy
4,900
+1,700
+53% +$506K 0.07% 123
2023
Q1 		$890K Sell
3,200
-5,100
-61% -$1.41M 0.02% 197
2022
Q4 		$2.3M Buy
+8,300
New +$2.34M 0.22% 80
2022
Q3 		– Sell
-5,800
Closed -$207K – 380
2022
Q2 		$207K Buy
5,800
+1,300
+29% +$266K 0.07% 165
2022
Q1 		$200K Sell
4,500
-5,700
-56% -$1.24M 0.03% 163
2021
Q4 		$304K Buy
+10,200
New +$2.62M 0.03% 152
2021
Q3 		– Sell
-6,100
Closed -$227K – 407
2021
Q2 		$227K Sell
6,100
-3,600
-37% -$1.09M 0.1% 182
2021
Q1 		$204K Buy
9,700
+400
+4% +$108K 0.01% 217
2020
Q4 		$301K Buy
+9,300
New +$2.4M 0.02% 137
2020
Q3 		– Sell
-7,100
Closed -$244K – 289
2020
Q2 		$244K Buy
+7,100
New +$2.13M 0.03% 123
2020
Q1 		– Sell
-22,200
Closed -$53K – 215
2019
Q4 		$53K Sell
22,200
-1,300
-6% -$361K 0.01% 168
2019
Q3 		$274K Buy
23,500
+3,500
+18% +$815K 0.04% 99
2019
Q2 		$290K Buy
+20,000
New +$4.62M 0.06% 112
2019
Q1 		– Sell
-12,200
Closed -$349K – 280
2018
Q4 		$349K Buy
+12,200
New +$3.89M 0.15% 90

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

XR Securities's BIIB Position: Q2 2023 in Review

XR Securities sold out of Biogen (BIIB) in Q2 2023, closing a stake of 1,122 shares — an estimated $334K sold.

XR Securities first reported a position in BIIB in Q3 2018 and held it in 11 quarters. The position peaked at $1.87M in Q3 2019. 1,008 funds tracked by Wall St. Rank hold BIIB as of Q2 2023.

  • XR Securities reported no remaining Biogen position as of Q2 2023 after selling out during the quarter.
  • XR Securities sold 1,122 Biogen shares in Q2 2023, an estimated $334K.
  • XR Securities first reported a position in Biogen in Q3 2018 and held it in 11 quarters.
  • XR Securities's Biogen position peaked at $1.87M in Q3 2019.
  • 1,008 funds tracked by Wall St. Rank held Biogen as of Q2 2023.

Based on XR Securities's 13F filing for Q2 2023, filed 8 Aug 2023.